NKTR-255 in Relapsed/Refractory Multiple Myeloma & Non Hodgkin Lymphoma & Combined With Daratumumab for Multiple Myeloma
Conditions: Multiple Myeloma; Non Hodgkin Lymphoma Interventions: Drug: NKTR-255; Drug: Daratumumab Sponsor: Nektar Therapeutics Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials